TET2 and acute myeloid leukemia: In conclusion, these results suggest that while TET2 mutations in AML are associated with many of the same methylation changes as in CHIP and CCUS, they are also associated with hypermethylation at a large number of other sites, especially at sites associated with active enhancers in HSCs but not in mature monocytes.